These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36241767)

  • 21. Emerging From the Haze: A Multicenter, Controlled Pilot Study of a Multidimensional, Psychoeducation-Based Cognitive Rehabilitation Intervention for Breast Cancer Survivors Delivered With Telehealth Conferencing.
    Myers JS; Cook-Wiens G; Baynes R; Jo MY; Bailey C; Krigel S; Klemp J; Asher A
    Arch Phys Med Rehabil; 2020 Jun; 101(6):948-959. PubMed ID: 32179067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial.
    Ercoli LM; Petersen L; Hunter AM; Castellon SA; Kwan L; Kahn-Mills BA; Embree LM; Cernin PA; Leuchter AF; Ganz PA
    Psychooncology; 2015 Nov; 24(11):1360-7. PubMed ID: 25759235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
    Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
    J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
    Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
    Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.
    Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
    Sherman DS; Mauser J; Nuno M; Sherzai D
    Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment experienced by Chinese breast cancer survivors.
    Chen D; Mackenzie L; Hossain SZ; Wang JX; Jiang PL; Wang Y; Qin L; Zhen J; Jia J
    Sci Rep; 2023 Dec; 13(1):22245. PubMed ID: 38097726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Web-based cognitive rehabilitation for survivors of adult cancer: A randomised controlled trial.
    Mihuta ME; Green HJ; Shum DHK
    Psychooncology; 2018 Apr; 27(4):1172-1179. PubMed ID: 29266524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.
    Wagner LI; Gray RJ; Sparano JA; Whelan TJ; Garcia SF; Yanez B; Tevaarwerk AJ; Carlos RC; Albain KS; Olson JA; Goetz MP; Pritchard KI; Hayes DF; Geyer CE; Dees EC; McCaskill-Stevens WJ; Minasian LM; Sledge GW; Cella D
    J Clin Oncol; 2020 Jun; 38(17):1875-1886. PubMed ID: 32271671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.
    Tometich DB; Small BJ; Carroll JE; Zhai W; Luta G; Zhou X; Kobayashi LC; Ahles T; Saykin AJ; Clapp JD; Jim HSL; Jacobsen PB; Hurria A; Graham D; McDonald BC; Denduluri N; Extermann M; Isaacs C; Dilawari A; Root J; Rini C; Mandelblatt JS;
    J Pain Symptom Manage; 2019 Mar; 57(3):596-606. PubMed ID: 30472317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study.
    Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K
    Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.
    Root JC; Zhou X; Ahn J; Small BJ; Zhai W; Bethea T; Carroll JE; Cohen HJ; Dilawari A; Extermann M; Graham D; Isaacs C; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher K; Saykin AJ; Van Dyk K; Mandelblatt JS; Ahles TA
    Breast Cancer Res Treat; 2022 Jul; 194(2):413-422. PubMed ID: 35587324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive problems of breast cancer survivors on proton pump inhibitors.
    Madison AA; Woody A; Bailey B; Lustberg MB; Ramaswamy B; Wesolowski R; Williams N; Reinbolt R; VanDeusen JB; Sardesai S; Malarkey WB; Kiecolt-Glaser JK
    J Cancer Surviv; 2020 Apr; 14(2):226-234. PubMed ID: 31933149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors.
    Von Ah D; Crouch AD; Monahan PO; Stump TE; Unverzagt FW; Storey S; Cohee AA; Cella D; Champion VL
    J Cancer Surviv; 2022 Aug; 16(4):812-822. PubMed ID: 34173970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and protocol for a randomized waitlist controlled trial of videoconference delivered cognitive behaviour therapy for insomnia (CBT-I) to improve perceived cognitive impairment (PCI) among cancer survivors.
    Garland SN; Savard J; Dalton K; Walsh NA; Seal M; Rash J; Browne S; Urquhart R; Thoms J; Gadag V; Laing K
    Contemp Clin Trials; 2021 Apr; 103():106322. PubMed ID: 33588077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
    Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H
    Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems.
    Gutenkunst SL; Vardy JL; Dhillon HM; Bell ML
    Support Care Cancer; 2021 Mar; 29(3):1377-1386. PubMed ID: 32666213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.